Praxis Precision Medicines, Inc.
PRAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.17 | 0.02 | -0.03 | 0.12 |
| FCF Yield | -9.56% | -75.68% | -169.07% | -15.02% |
| EV / EBITDA | -5.83 | -0.54 | -0.24 | -4.20 |
| Quality | ||||
| ROIC | -44.80% | -172.35% | -262.86% | -65.59% |
| Gross Margin | -1,681.98% | -3,445.81% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.72 | 0.90 | 0.86 | 0.75 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -18.50% | 40.06% | -47.68% | -138.69% |
| Safety | ||||
| Net Debt / EBITDA | 1.07 | 0.63 | 0.27 | 0.80 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -30.00 | -24.46 | -34.68 | 0.00 |